The global neurovascular devices market size was valued at USD 7.8 billion in 2025 and is estimated to reach USD 8.2 billion in 2026. The market is projected to reach USD 11.9 billion by 2033, expanding at a CAGR of 5.4% from 2026 to 2033. North America dominated the market with a 30.2% revenue share in 2025, supported by advanced healthcare infrastructure, high procedural volumes, and strong adoption of minimally invasive neurointerventional therapies. Rising prevalence of stroke, cerebral aneurysms, and other neurovascular disorders, along with continued advances in medical technology, is strengthening demand for specialized neurovascular devices.

The market is being supported by the growing burden of cerebrovascular diseases and increasing adoption of minimally invasive procedures. According to Grand View Research, more than 12 million new strokes occur annually, while approximately 25% of the global population is expected to experience a stroke during their lifetime. These trends are increasing the need for thrombectomy systems, embolization devices, microcatheters, flow diverters, and other neurovascular technologies.

Download a free sample copy of the Neurovascular Devices Market report to understand detailed coverage and inclusions in the final report

Market Segmentation & Ecosystem Dynamics

By Device

• Cerebral Embolization & Aneurysm Coiling Devices: Held the largest market share of 37.7% in 2025. This category includes embolic coils, flow diversion coils, and liquid embolic agents used for the management of cerebral aneurysms and other neurovascular conditions. Ongoing development of advanced and smart aneurysm coils is supporting segment expansion.

• Neurothrombectomy Devices: Expected to register the fastest growth during the forecast period, driven by the increasing prevalence of acute ischemic stroke and growing demand for rapid endovascular intervention. Manufacturers are developing thrombectomy systems with improved clot retrieval, trackability, aspiration efficiency, and access to complex cerebral vessels.

• Support Devices: Microcatheters, guidewires, access devices, and related technologies remain important components of neurointerventional procedures, supporting physicians during complex vascular interventions.

By Therapeutic Applications

• Stroke: Held the largest share of the market at 57.0% in 2025. The segment's dominance is associated with the increasing prevalence of stroke and growing development and adoption of neurovascular devices designed for stroke treatment. Mechanical thrombectomy and other minimally invasive interventions are supporting demand.

• Cerebral Aneurysm: Projected to witness the fastest growth during the forecast period, supported by increasing incidental detection, rising adoption of minimally invasive endovascular therapies, and continued advances in embolization technologies. Coil embolization and flow diversion procedures are contributing to segment expansion.

By End Use

• Hospitals: Dominated the market with a 70.9% revenue share in 2025. The segment benefits from the high volume of neurovascular procedures conducted in hospitals, availability of advanced infrastructure, specialized stroke centers, and skilled healthcare professionals. Hospital-based clinical trials and collaborations with medical device companies are also supporting growth.

• Others: Includes ambulatory surgery centers, emergency care centers, and long-term care facilities. This segment is expected to register the fastest CAGR through 2033, supported by the expansion of ambulatory facilities and the increasing shift toward minimally invasive and outpatient neurointerventional procedures.

Key Growth Drivers & Challenges

• Rising Stroke Prevalence: The increasing incidence of ischemic and hemorrhagic stroke is generating demand for thrombectomy systems, embolization devices, neurovascular stents, guidewires, and microcatheters. Hospitals are also expanding dedicated stroke treatment programs and neurointerventional centers to address the growing disease burden.

• Minimally Invasive Treatment: Increasing clinical preference for minimally invasive neurointerventional procedures is supporting adoption of advanced devices. These approaches can enable faster recovery and expand treatment options for complex neurological conditions.

• Technological Innovation: Advancements in thrombectomy devices, flow diverters, embolization systems, neurovascular stents, and microcatheters are improving procedural effectiveness and expanding treatment possibilities. Companies are also developing devices with enhanced navigability, stability, and clot-retrieval capabilities.

• High Treatment Costs: The high cost of neurovascular devices and interventional procedures remains a market restraint, particularly in cost-sensitive healthcare systems. Advanced imaging equipment, specialized devices, and trained professionals can increase the overall cost of treatment and limit adoption in some developing regions.

• Thrombectomy Opportunities: Advanced thrombectomy and aspiration systems represent an important growth opportunity as healthcare providers prioritize rapid intervention for acute ischemic stroke. Newer systems are being developed with improved clot capture, aspiration efficiency, trackability, and access to difficult cerebral vessels.

Regional Market Outlook

• North America: Dominated the neurovascular devices market with a 30.2% revenue share in 2025. Advanced healthcare infrastructure, high procedural volumes, specialized stroke centers, favorable reimbursement frameworks, and early adoption of innovative technologies support regional leadership. The U.S. held the largest country-level share in 2025.

• Europe: The market is supported by an expanding geriatric population, advancements in neurovascular technologies, growing awareness of stroke management, and increasing adoption of minimally invasive procedures. The UK and Germany represent important markets within the region.

• Asia Pacific: Expected to register the fastest CAGR from 2026 to 2033. A large patient population, increasing prevalence of neurological disorders, improvements in healthcare infrastructure, and growing demand for advanced and cost-effective medical technologies are creating significant opportunities.

• Latin America: Growth is being supported by increasing government healthcare investments, improving diagnostic capabilities, greater awareness of neurological disorders, and rising demand for minimally invasive treatment options.

• Middle East & Africa: The region is experiencing steady growth as stroke and other neurovascular disorders become more prevalent. Investments in advanced healthcare infrastructure and specialized stroke facilities are contributing to greater demand for neurovascular interventions.

Looking for more specific insights? Customize this report to suite your business need

Competitive Landscape

The neurovascular devices market features established medical technology companies and specialized neurovascular manufacturers competing through product innovation, regulatory approvals, strategic partnerships, and regional expansion. Key companies profiled by Grand View Research include:

• Medtronic

• Stryker

• Johnson & Johnson and its affiliates

• Penumbra, Inc.

• MicroPort Scientific Corporation

• Terumo Corporation

• ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.

• NeuroSafe Medical Co., Ltd.

• Rapid Medical

• Evasc Neurovascular Enterprises

• Lepu Medical Technology(Beijing) Co., Ltd.

• Acandis GmbH

• phenox GmbH (Wallaby Medical)

Companies are increasingly investing in thrombectomy, embolization, aneurysm management, and procedural support technologies. Product launches and collaborations are also shaping the competitive environment. For example, Penumbra launched BMX 81 and BMX 96 neuro access catheters in Europe in June 2024, while Emboa Medical launched its Thrombus Retrieval Aspiration Platform in February 2025.

Overall, the neurovascular devices market is expanding as the global burden of stroke and other cerebrovascular disorders increases. The combination of minimally invasive treatment adoption, technological advancements, specialized stroke infrastructure, and growing demand for rapid intervention is creating new opportunities for device manufacturers. With the market expected to grow from USD 8.2 billion in 2026 to USD 11.9 billion by 2033 at a CAGR of 5.4%, continued innovation in thrombectomy, embolization, aneurysm coiling, and neurovascular support technologies is expected to shape the market through 2033.